Connect Biopharma Holdings Limited (CNTB) vs Fractyl Health, Inc. (GUTS)

A side-by-side comparison of Connect Biopharma Holdings Limited and Fractyl Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Connect Biopharma Holdings Limited logo
CNTB
Connect Biopharma Holdings Limited
$56M
$0.89HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Fractyl Health, Inc. logo
GUTS
Fractyl Health, Inc.
$59M
$4.46HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT

Total return — CNTB vs GUTS

growth of $100 · dividends reinvested · last 3y
CNTB -11.1% (-3.8%/yr)GUTS -97.0% (-69.1%/yr)CNTB compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$89$3
CNTB GUTS

CNTB vs GUTS: by the numbers

  • •GUTS is the larger company ($59M vs $56M market cap).
  • •Both run net losses; GUTS's is the smaller (0.00% vs -86687.50% net margin).

Metrics side by side

Valuation

MetricCNTBGUTS
P/B ratio2.08N/A

Profitability

MetricCNTBGUTS
Gross margin100.00%0.00%
Operating margin-90740.62%0.00%
Net margin-86687.50%0.00%
ROE-132.16%N/A
ROIC-136.77%-129.67%

Growth (annualized)

MetricCNTBGUTS
Total return CAGR (5Y)-47.22%N/A

Go deeper

Full CNTB analysisFull GUTS analysisInteractive comparison tool

Dig into the metrics

Connect Biopharma ROEFractyl Health ROEConnect Biopharma operating marginFractyl Health operating marginConnect Biopharma revenue growthFractyl Health revenue growthConnect Biopharma free cash flowFractyl Health free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.